Aurobindo Pharma said that the United States Food and Drug Administration (US FDA) inspected the Unit-II, a formulation manufacturing facility of its wholly owned subsidiary Eugia Pharma Specialities that is situated at Bhiwadi, Rajasthan.
Subscribe To Our Free Newsletter |